5-(4-氯苯基)吡啶-2-胺 | 84596-08-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 中文名称: 5-(4-氯苯基)吡啶-2-胺
• 英文名称: 5-(4-chlorophenyl)pyridin-2-amine
• 英文别名: 5-(4-chlorophenyl)pyridin-2-ylamine；5-(4-Chlorophenyl)-2-pyridylamine；2-amino-5-(4-chlorophenyl)-pyridine
• CAS: 84596-08-7
• 化学式: C₁₁H₉ClN₂
• 分子量: 204.659
• InChiKey: LVARCJGOURVXJL-UHFFFAOYSA-N

物化性质

• 沸点：
  352℃
• 密度：
  1.261
• 闪点：
  167℃

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  14
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  38.9
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 海关编码：
  2933399090
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 5-(4-Chlorophenyl)pyridin-2-amine
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 5-(4-Chlorophenyl)pyridin-2-amine
CAS number: 84596-08-7

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C11H9ClN2
Molecular weight: 204.7

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen chloride.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  5-(4-氯苯基)吡啶-2-胺 在 1,1'-双(二苯膦基)二茂铁二氯化钯(II)二氯甲烷复合物 盐酸 、 N-碘代丁二酰亚胺 、 三氟乙酸 、 lithium hydroxide 作用下， 以 1,4-二氧六环 、 水 、 N,N-二甲基甲酰胺 为溶剂， 反应 27.5h， 生成 5-(4-氯苯基)-1H-吡咯并[2,3-b]吡啶
  参考文献：
  名称：

  Novel Processes for the manufacture of Propane-1-sulfonic acid -amide

  摘要：

  根据本发明提供了制备化合物1的新工艺，以及用于这些工艺中的中间体和关键中间体的新合成路线。

  公开号：

  US20120022258A1
• 作为产物：
  描述：

  在 sodium hydroxide 作用下， 以 水 为溶剂， 生成 5-(4-氯苯基)吡啶-2-胺
  参考文献：
  名称：

  Novel Processes for the manufacture of Propane-1-sulfonic acid -amide

  摘要：

  根据本发明提供了制备化合物1的新工艺，以及用于这些工艺中的中间体和关键中间体的新合成路线。

  公开号：

  US20120022258A1

文献信息

• 1-Benzoyl-3-(arylphyridyl)urea compounds
  申请人：Eli Lilly and Company

  公开号：US04405552A1

  公开（公告）日：1983-09-20

  The present invention is directed to 1-benzoyl-3-(arylpyridyl)urea compounds useful as insecticides.

  本发明涉及作为杀虫剂有用的1-苯甲酰基-3-(芳基吡啶基)脲化合物。
• One-Pot Tandem Amidation, Knoevenagel Condensation, and Palladium-Catalyzed Wacker Type Oxidation/C–O Coupling: Synthesis of Chromeno-Annulated Imidazopyridines
  作者：Khima Pandey、Krishnan Rangan、Anil Kumar

  DOI：10.1021/acs.joc.8b00884

  日期：2018.8.3

  direct one-pot synthesis of chromeno-annulated imidazo[1,2-a]pyridines is achieved by the reaction of 2-amino-1-(2-ethoxy-2-oxoethyl)pyridinium salts with 2-bromoarylaldehydes using Pd(TFA)2 as a catalyst and Cu(OAc)2 as an oxidant. The overall strategy involves tandem base-mediated amidation and Knoevenagel condensation, followed by palladium-catalyzed Wacker type oxidation and intramolecular C–O coupling

  通过使用Pd（TFA）使2-氨基-1-（2-乙氧基-2-氧乙基）吡啶鎓盐与2-溴芳基醛反应，可直接合成一氧化铬修饰的咪唑并[1,2- a ]吡啶）2作为催化剂，Cu（OAc）2作为氧化剂。总体策略涉及串联碱基介导的酰胺化和Knoevenagel缩合，然后进行钯催化的Wacker型氧化和分子内C–O偶联反应。该方法简单，耐受不同的官能团，并给出中等程度到良好的产色量[2'，3'：4,5]咪唑并[1,2 - a ]吡啶-12-衍生物。发达的串联反应也成功地用于合成吡喃并稠合的咪唑并[1,2- a]。通过使用3-溴-3-芳基丙烯醛制备]吡啶。
• Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
  申请人：Boehringer Ingelheim Pharma GmbH & Co. KG

  公开号：US20040209865A1

  公开（公告）日：2004-10-21

  The present invention relates to alkyne compounds of general formula I 1 wherein the groups and residues A, B, W, X, Y, Z, R 1 and R 2 have the meanings given in claim 1 . The invention further relates to pharmaceutical compositions containing at least one alkyne according to the invention. In view of their MCH-receptor antagonistic activity the pharmaceutical compositions according to the invention are suitable for the treatment of metabolic disorders and/or eating disorders, particularly obesity, bulimia, anorexia, hyperphagia and diabetes.

  本发明涉及一般式I的炔烃化合物 1 其中基团和残基A、B、W、X、Y、Z、R 1 和R 2 具有权利要求中给出的含义。本发明还涉及含有根据本发明至少一种炔烃的药物组合物。鉴于它们的MCH受体拮抗活性，根据本发明的药物组合物适用于治疗代谢紊乱和/或进食紊乱，特别是肥胖症、暴食症、厌食症、过度进食和糖尿病。
• Metal-free synthesis of pyridin-2-yl ureas from 2-aminopyridinium salts
  作者：Saroj、Om P.S. Patel、Krishnan Rangan、Anil Kumar

  DOI：10.1016/j.tetlet.2019.07.030

  日期：2019.8

  domino approach has been developed for the synthesis of pyridin-2-yl urea derivatives via the reaction of 2-aminopyridinium salts and arylamines. The developed strategy tolerated a wide range of functional groups and afforded pyridin-2-yl ureas in moderate to good yields. The reaction was postulated to involve tandem cyclization, intermolecular nucleophilic addition, ring opening, and demethylation.

  通过2-氨基吡啶鎓盐和芳基胺的反应合成吡啶-2-基脲衍生物，已经开发出了前所未有的碱促进多米诺骨牌方法。所开发的策略可耐受各种官能团，并以中等至良好的产率提供吡啶-2-基脲。假定该反应涉及串联环化，分子间亲核加成，开环和去甲基化。
• Acetylenyl-pyrazolo-pyrimidine derivatives
  申请人：McArthur Gatti Silvia

  公开号：US20060217387A1

  公开（公告）日：2006-09-28

  The present invention relates to compounds of formula (I): wherein R 1 to R 3 , A, M, L, E, G, and J are as defined in the description and claims. The invention also relates to a process for the manufacture of such compounds, pharmaceutical compositions containing them, and methods for treating CNS disorders.

  本发明涉及式(I)的化合物：其中R1到R3、A、M、L、E、G和J的定义如描述和索赔中所述。该发明还涉及一种制备此类化合物的方法、含有它们的药物组合物，以及治疗中枢神经系统疾病的方法。